Are there unique autoantigens triggering autoimmune diseases?
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Summary: Using three reference disease models ‐ insulin‐dependent diabetes mellitus (IDDM) as a prototype of T‐cell mediated organ‐specific autoimmune disease, myasthenia gravis (MG) as a prototype of auto and‐body‐inediated organ‐specific autoimmune disease and systemic lupus erythematosus (SLE) as a prototype of non‐organ‐specific autoimmune disease ‐ we have reached several conclusions: 1) All three diseases are associated with the presence of multiple autoantibodies and/or autoreactive T cells that recognize a large number of antigenic molecules. The apparent predominant role of certain antibodies in sotne diseases could relate to their functional properties stich as acetylcholine receptor (AChR) blockade for anti‐AChR autoantibodies in MG or anti‐dsDNA in SLE, 2) Major target antigens are clustered in the target cell affected by organ‐specific autoimmune diseases: β cells in IDDM, striated‐muscle cells in MG, or apopiotic cells in the case of SLE. 3) Antibodies and T cells recognize multiple epitopes in these molecules, 4) The most evident explanation for the observed clustering and diversity is autoantigen spreading. Spreading probably involves T cells secreting proinflammatory cytokines but also possibly antibodies as in the case of nucleosome autoantibodies in SLE. 5) The counterpart of antigen spreading is bystander suppression in which regulatory cytokines deviate the immune response towards a protective response, 6) The mechanisms underlying the initiation of the autoimmune response and antigen spreading are still undetermined. They could imply a direct abnormality of the target cell in the case of organ‐specific autoimmune diseases (e.g. infection with a virus showing a selective tropism for the target cell in organ‐specific autoimmune diseases, or loss of physiological regulation of major histocompatibility complex molecule expression) or could be consequence of a ubiquitous cell abnormality such as increased apoptosis in SLE. The respective roles of genetic and environmental factors in these triggering events remain to be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin antibodies in insulin-dependent diabetics before insulin treatment
Palmer, J. P., Asplin, C. M., Clemons, P., Lyen, K., Tatpati, O., Raghu, P. K., & Paquette, T. L. (1983) · Science · doi:10.1126/science.6362005 · Cited by 1,078
Atkinson, M. A., Bowman, M. A., Campbell, L., Darrow, B. L., Kaufman, D. L., & Maclaren, N. K. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117567 · Cited by 448
Cited by
Infections and autoimmune diseases
Bach, J.-F. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.09.024 · Cited by 358
Self-citationUse of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus
Amagai, M., Tsunoda, K., Suzuki, H., Nishifuji, K., Koyasu, S., & Nishikawa, T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8748 · Cited by 255
A historical view from thirty eventful years of immunotherapy in autoimmune diabetes
Bach, J.-F., & Chatenoud, L. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.07.009 · Cited by 41
Self-citation
Metadata
- Authors
- Bach, J. F., Koutouzov, S., & van Endert, P. M.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 1998-08
- Volume
- 164
- Issue
- 1
- Pages
- 139-155
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2049181366
- Cited by
- 88
- References
- 2
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Are there unique autoantigens triggering autoimmune diseases? https://app.cochat.ai/papers/10.1111/j.1600-065x.1998.tb01216.x
- The paper
- Bach, J. F., Koutouzov, S., & van Endert, P. M. (1998). Are there unique autoantigens triggering autoimmune diseases? Immunological Reviews. https://doi.org/10.1111/j.1600-065x.1998.tb01216.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.